• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Implantable Bioreactor for Kidney Cells

      Implantable Bioreactor for Kidney Cells

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Cells Release Insulin in Response to Music

      Cells Release Insulin in Response to Music

    • Radiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Wearable Ultrasound for Deep Tissue Monitoring

      Wearable Ultrasound for Deep Tissue Monitoring

    • Cardiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      3D Printed Heart Muscle Beats

      3D Printed Heart Muscle Beats

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Photonic Radar Monitors Breathing from a Distance

      Photonic Radar Monitors Breathing from a Distance

    • Surgery
      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Implantable Bioreactor for Kidney Cells

      Implantable Bioreactor for Kidney Cells

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

    • Nanomedicine
      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Optical Strain Sensors for Rehab

      Optical Strain Sensors for Rehab

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Brain Computer Interface Decodes Speech and Facial Expressions

      Brain Computer Interface Decodes Speech and Facial Expressions

      Semi-Automated Manufacture of E-Skin Sensors

      Semi-Automated Manufacture of E-Skin Sensors

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

StudyHippo Aims to Connect Patients with Clinical Trials: Interview with Co-Founder, Alex Harding

July 8th, 2013 Shiv Gaglani Exclusive

StudyHippoIf you’re located near an academic medical center, you’ve probably noticed the nearly-ubiquitous advertisements recruiting clinical trial participants: Are you an 18-65 year old with Type 2 Diabetes? Do you suffer from dry skin and itchy eyes? Then this study is right for you!

From a medical science perspective, these studies are important because they often serve as the basis for new treatments and interventions. Thus, it is crucial that a representative group of people participate. From the patient’s perspective, there are both health and financial incentives to participate. StudyHippo is a new start-up out of Boston that aims to connect these two populations – clinical researchers and patients. Here’s their intro video:

 

We had the chance to interview Alex Harding, a co-founder of StudyHippo and MD/MBA student at Harvard Business School and the Johns Hopkins School of Medicine. Here’s what he had to say about the startup:

 

Shiv Gaglani, Medgadget: How did you come up with the idea for StudyHippo?

Alex Harding

Alex Harding, StudyHippo: I co-founded StudyHippo with a team of my business school classmates. Our team was interested in pain points in medical care that have not been properly addressed. There are so many health care start-ups out there, and we wanted to focus on an area that hadn’t gotten much attention.

One of my teammates, Rena Xu, is a medical student at Harvard and has worked in clinical research and as a member of an Institutional Review Board (IRB) for clinical studies at Harvard. She was the one who originally had the idea to create a website that would help clinical researchers find study subjects and help individuals find studies they could participate in. We all realized right away that this was a huge pain point–it’s essential for the advancement of medical research that researchers recruit subjects in a timely and cost effective manner, and it is such a challenge for researchers to do so today.

Researchers have told us that StudyHippo is exactly the tool they have been hoping for, and that it will make a huge difference in their recruitment process. And we’ve gotten great traction in signing people up for our website. There is a lot of pent up demand in the market due to historical inefficiencies.

 

Medgadget: Are you focusing on any particular trial types?

Harding: Yes, we have been targeting diabetes trials and diabetic participants in Boston. One of the biggest keys to success for us is reaching a critical mass of both researchers and participants. There’s a big network effect: the more users we have, the more valuable our service is to researchers. The more value we bring to researchers, the more high-quality studies they will post. And the more high-quality studies that are posted, the more users will sign up. So our strategy has been to target diabetes studies and healthy subject studies in Boston. There is a big market of studies and potential participants in both these segments, so we believe we will be able to maximize matches for researchers and users by focusing on these segments. We have been getting a lot of interest from both researchers and users in both the diabetes and healthy subject categories. There’s just so much excitement about a product that does what we’re doing. We’ve begun to get to critical mass in these sub-market, and we are evaluating other fields and regions to target next.

 

Medgadget: Is anyone else trying to more efficiently match participants to trials?

Harding: There are a few other sites trying to do something similar to StudyHippo.com. trialx.com and clinicalconnection.com are a couple examples. There are some big differences in our approach, though. Those sites scrape data off clinicaltrials.gov, which is a public repository for ongoing clinical studies. The problem is, clinicaltrials.gov is principally a tool for researchers to browse studies, and the language on the site is highly technical and not focused on what participants would want to know. Those sites are also not geographically focused, and does not provide a comprehensive set of local studies. So you’ll see studies going on in Wichita even if you live in Boston, but you won’t be able to see anywhere near all the Boston studies that are available. StudyHippo.com has studies posted that use simpler language targeted towards what study subjects need to know and we are focusing our roll-out geographically to ensure that our users have the best selection near them. We also present the crucial details for subjects in a succinct format: distance from the user’s home, time commitment, and compensation amount. That information is usually not available on clinicaltrials.gov.

 

Medgadget: How do you work with user accounts/privacy given that many trials may be about sensitive topics?

Harding: The privacy of our user information is of the utmost importance to us. We never share data on our users. We are also focused on being an informational site. At this point, we don’t make the connection with researchers on behalf of the user and are not in the business of obtaining private health information from our users. The user account information to the bare essentials to ensure that our users get matched to studies they are interested in.

 

Medgadget: What is the revenue model for StudyHippo and how large is the market (both in terms of number of people/studies and revenue potential)?

Harding: We charge a nominal fee for researchers to post their studies with us. At this time, we have launched our beta product and are focused on recruiting high quality research partners to show them how valuable our service is.

The market for research subject recruitment is huge. Of the $35B spent on clinical research every year, subject recruitment is the largest single expense, comprising billions of dollars every year! Of course, we don’t expect to capture that entire market, but we have made financial projections that show that we have the potential–even under conservative assumptions–to build a substantial business in a few years.

divider

Link: StudyHippo…

Shiv Gaglani

Shiv Gaglani is an MD/MBA candidate at the Johns Hopkins School of Medicine and Harvard Business School. In addition to curating the Smartphone Physical (www.smartphonephysical.org), he also contributes regularly to CardioSource World News and Emergency Physicians Monthly. He is interested in developing scalable, tech-based solutions for medicine and education; to this end he is the co-founder of the medical education tech start-up, Osmosis (www.osmosis.org).  More about Shiv: http://about.me/sgaglani

Sponsored
Clarius L20 HD3 Receives Highest Image Quality Ranking Among Five Point-of-Care Ultrasound Devices

Clarius L20 HD3 Receives Highest Image Quality Ranking Among Five Point-of-Care Ultrasound Devices

Viral Vector Manufacturing in Gene Therapy and Vaccine Development

Health and Clean Air: Why Indoor Ventilation Matters

Health and Clean Air: Why Indoor Ventilation Matters

New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

MedTech Outlook 2023 for Latin America Released

MedTech Outlook 2023 for Latin America Released

interviews & reviews
Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email